Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Series TitleSeries Title
-
Reading LevelReading Level
-
YearFrom:-To:
-
More FiltersMore FiltersContent TypeItem TypeIs Full-Text AvailableSubjectPublisherSourceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
18,529
result(s) for
"Psychometrics - methods"
Sort by:
Screening for posttraumatic stress disorder in ARDS survivors: validation of the Impact of Event Scale-6 (IES-6)
by
Bienvenu, O. Joseph
,
Leoutsakos, Jeannie-Marie S.
,
Li, Ximin
in
Adult
,
Adult respiratory distress syndrome
,
Aged
2019
Background
Posttraumatic stress disorder (PTSD) symptoms are common in acute respiratory distress syndrome (ARDS) survivors. Brief screening instruments are needed for clinical and research purposes. We evaluated internal consistency, external construct, and criterion validity of the Impact of Event Scale-6 (IES-6; 6 items) compared to the original Impact of Event Scale—Revised (IES-R; 22 items) and to the Clinician Administered PTSD Scale (CAPS) reference standard evaluation in ARDS survivors.
Methods
This study is a secondary analysis from two independent multi-site, prospective studies of ARDS survivors. Measures of internal consistency, and external construct and criterion validity were evaluated.
Results
A total of 1001 ARDS survivors (51% female, 76% white, mean (SD) age 49 (14) years) were evaluated. The IES-6 demonstrated internal consistency over multiple time points up to 5 years after ARDS (Cronbach’s alpha = 0.96; 95% confidence interval (CI) 0.94 to 0.97). The IES-6 demonstrated stronger correlations with related constructs (e.g., anxiety and depression; |r| = 0.32 to 0.52) and weaker correlations with unrelated constructs (e.g., physical function and healthcare utilization measures (|r| = 0.02 to 0.27). Criterion validity evaluation with the CAPS diagnosis of PTSD in a subsample of 60 participants yielded an area under receiver operating characteristic curve (95% CI) of 0.93 (0.86, 1.00), with an IES-6 cutoff score of 1.75 yielding 0.88 sensitivity and 0.85 specificity.
Conclusions
The IES-6 is reliable and valid for screening for PTSD in ARDS survivors and may be useful in clinical and research settings.
Journal Article
Virtual reality as a distraction technique for pain and anxiety among patients with breast cancer: A randomized control trial
2019
The goal of this study was to assess the effectiveness of immersive virtual reality (VR) distraction technology in reducing pain and anxiety among female patients with breast cancer.
A randomized control trial design was used with a sample of 80 female patients with breast cancer at a specialized cancer center in Jordan. Participants were randomly assigned into intervention and comparison groups.ResultThe study findings showed that one session of the immersive VR plus morphine made a significant reduction in pain and anxiety self-reported scores, compared with morphine alone, in breast cancer patients.Significance of resultsImmersive VR is an effective distraction intervention for managing pain and anxiety among breast cancer patients. Using immersive VR as an adjuvant intervention is more effective than morphine alone in relieving pain and anxiety; furthermore, VR is a safe intervention more than pharmacological treatment.
Journal Article
Efficacy and Outcomes of a Music-Based Emotion Regulation Mobile App in Distressed Young People: Randomized Controlled Trial
by
Quinn, Catherine
,
Kavanagh, David J
,
Dingle, Genevieve
in
Adolescent
,
Adult
,
Emotional Regulation
2019
Emotion dysregulation increases the risk of depression, anxiety, and substance use disorders. Music can help regulate emotions, and mobile phones provide constant access to it. The Music eScape mobile app teaches young people how to identify and manage emotions using music.
This study aimed to examine the effects of using Music eScape on emotion regulation, distress, and well-being at 1, 2, 3, and 6 months. Moderators of outcomes and user ratings of app quality were also examined.
A randomized controlled trial compared immediate versus 1-month delayed access to Music eScape in 169 young people (aged 16 to 25 years) with at least mild levels of mental distress (Kessler 10 score>17).
No significant differences between immediate and delayed groups on emotion regulation, distress, or well-being were found at 1 month. Both groups achieved significant improvements in 5 of the 6 emotion regulation skills, mental distress, and well-being at 2, 3, and 6 months. Unhealthy music use moderated improvements on 3 emotion regulation skills. Users gave the app a high mean quality rating (mean 3.8 [SD 0.6]) out of 5.
Music eScape has the potential to provide a highly accessible way of improving young people's emotion regulation skills, but further testing is required to determine its efficacy. Targeting unhealthy music use in distressed young people may improve their emotion regulation skills.
Australian New Zealand Clinical Trials Registry ACTRN12615000051549; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365974.
Journal Article
Invariant measurement with raters and rating scales : Rasch models for rater-mediated assessments
\"The purpose of this book is to present methods for developing, evaluating and maintaining rater-mediated assessment systems. Rater-mediated assessments involve ratings that are assigned by raters to persons responding to constructed-response items (e.g., written essays and teacher portfolios) and other types of performance assessments. This book addresses the following topics: (1) introduction to the principles of invariant measurement, (2) application of the principles of invariant measurement to rater-mediated assessments, (3) description of the lens model for rater judgments, (4) integration of principles of invariant measurement with the lens model of cognitive processes of raters, (5) illustration of substantive and psychometric issues related to rater-mediated assessments in terms of validity, reliability, and fairness, and (6) discussion of theoretical and practical issues related to rater-mediated assessment systems. Invariant measurement is fast becoming the dominant paradigm for assessment systems around the world, and this book provides an invaluable resource for graduate students, measurement practitioners, substantive theorists in the human sciences, and other individuals interested in invariant measurement when judgments are obtained with rating scales\"-- Provided by publisher.
Measuring visual ability in linguistically diverse populations
by
Hooper, Madison A.
,
Tomarken, Andrew
,
Gauthier, Isabel
in
Adolescent
,
Adult
,
Behavioral Science and Psychology
2024
Measurement of object recognition (OR) ability could predict learning and success in real-world settings, and there is hope that it may reduce bias often observed in cognitive tests. Although the measurement of visual OR is not expected to be influenced by the language of participants or the language of instructions, these assumptions remain largely untested. Here, we address the challenges of measuring OR abilities across linguistically diverse populations. In Study 1, we find that English–Spanish bilinguals, when randomly assigned to the English or Spanish version of the novel object memory test (NOMT), exhibit a highly similar overall performance. Study 2 extends this by assessing psychometric equivalence using an approach grounded in item response theory (IRT). We examined whether groups fluent in English or Spanish differed in (a) latent OR ability as assessed by a three-parameter logistic IRT model, and (2) the mapping of observed item responses on the latent OR construct, as assessed by differential item functioning (DIF) analyses. Spanish speakers performed better than English speakers, a difference we suggest is due to motivational differences between groups of vastly different size on the Prolific platform. That we found no substantial DIF between the groups tested in English or Spanish on the NOMT indicates measurement invariance. The feasibility of increasing diversity by combining groups tested in different languages remains unexplored. Adopting this approach could enable visual scientists to enhance diversity, equity, and inclusion in their research, and potentially in the broader application of their work in society.
Journal Article
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores
by
Montgomery, A Bruce
,
Quittner, Alexandra L
,
Li, Xiaoming
in
Administration, Inhalation
,
Adolescent
,
Adult
2015
Background The Quality of Life-Bronchiectasis (QOL-B), a self-administered, patient-reported outcome measure assessing symptoms, functioning and health-related quality of life for patients with non-cystic fibrosis (CF) bronchiectasis, contains 37 items on 8 scales (Respiratory Symptoms, Physical, Role, Emotional and Social Functioning, Vitality, Health Perceptions and Treatment Burden). Methods Psychometric analyses of QOL-B V.3.0 used data from two double-blind, multicentre, randomised, placebo-controlled, phase III trials of aztreonam for inhalation solution (AZLI) in 542 patients with non-CF bronchiectasis and Gram-negative endobronchial infection. Results Excellent internal consistency (Cronbach's α ≥0.70) and 2-week test–retest reliability (intraclass correlation coefficients ≥0.72) were demonstrated for each scale. Convergent validity with 6 min walk test was observed for Physical and Role Functioning scores. No floor or ceiling effects (baseline scores of 0 or 100) were found for the Respiratory Symptoms scale (primary endpoint of trials). Baseline Respiratory Symptoms scores discriminated between patients based on baseline FEV1% predicted in only one trial. The minimal important difference score for the Respiratory Symptoms scale was 8.0 points. AZLI did not show efficacy in the two phase III trials. QOL-B responsivity to treatment was assessed by examining changes from baseline QOL-B scores at study visits at which protocol-defined pulmonary exacerbations were reported. Mean Respiratory Symptoms scores decreased 14.0 and 14.2 points from baseline for placebo-treated and AZLI-treated patients with exacerbations, indicating that worsening respiratory symptoms were reflected in clinically meaningful changes in QOL-B scores. Conclusions Previously established content validity, reliability and responsivity of the QOL-B are confirmed by this final validation study. The QOL-B is available for use in clinical trials and routine clinical practice.
Journal Article